Axa maintained its position in NCI, Inc. (NASDAQ:NCIT) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,342 shares of the information technology services provider’s stock at the end of the first quarter. Axa owned 0.25% of NCI worth $502,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of NCIT. Algert Global LLC raised its position in NCI by 10.8% in the first quarter. Algert Global LLC now owns 12,155 shares of the information technology services provider’s stock worth $183,000 after buying an additional 1,180 shares in the last quarter. Teachers Advisors LLC raised its position in NCI by 44.1% in the fourth quarter. Teachers Advisors LLC now owns 13,212 shares of the information technology services provider’s stock worth $184,000 after buying an additional 4,044 shares in the last quarter. Hancock Holding Co. bought a new position in NCI during the first quarter worth approximately $189,000. Russell Investments Group Ltd. bought a new position in NCI during the fourth quarter worth approximately $216,000. Finally, Bank of New York Mellon Corp raised its position in NCI by 4.4% in the first quarter. Bank of New York Mellon Corp now owns 27,972 shares of the information technology services provider’s stock worth $421,000 after buying an additional 1,184 shares in the last quarter. Institutional investors and hedge funds own 39.04% of the company’s stock.
NCI, Inc. (NASDAQ:NCIT) opened at 20.35 on Thursday. NCI, Inc. has a 1-year low of $10.98 and a 1-year high of $21.00. The company’s 50 day moving average is $18.39 and its 200-day moving average is $15.07. The firm has a market cap of $275.76 million, a price-to-earnings ratio of 45.53 and a beta of 0.98.
NCI (NASDAQ:NCIT) last announced its earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.21 by $0.04. NCI had a net margin of 2.13% and a return on equity of 11.73%. The company had revenue of $78.75 million for the quarter, compared to analyst estimates of $76.55 million. On average, analysts predict that NCI, Inc. will post $1.01 EPS for the current fiscal year.
A number of research analysts recently commented on the stock. Cowen and Company set a $24.00 price objective on shares of NCI and gave the company a “buy” rating in a research note on Thursday, June 8th. ValuEngine upgraded shares of NCI from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. FBR & Co reiterated a “hold” rating and set a $11.00 price objective on shares of NCI in a research note on Tuesday, April 4th. Noble Financial reiterated a “buy” rating on shares of NCI in a research note on Wednesday, June 14th. Finally, Zacks Investment Research lowered shares of NCI from a “hold” rating to a “sell” rating in a research note on Saturday, April 8th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. NCI currently has a consensus rating of “Buy” and a consensus target price of $17.50.
NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.
Receive News & Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related companies with MarketBeat.com's FREE daily email newsletter.